← Back to home

PATIENTS WITH ADVANCED SOLID TUMORS WHO DISCONTINUED TREATMENT DUE TO IRAE

Clinical trials for PATIENTS WITH ADVANCED SOLID TUMORS WHO DISCONTINUED TREATMENT DUE TO IRAE explained in plain language.

Never miss a new study

Get alerted when new PATIENTS WITH ADVANCED SOLID TUMORS WHO DISCONTINUED TREATMENT DUE TO IRAE trials appear

Sign up with your email to follow new studies for PATIENTS WITH ADVANCED SOLID TUMORS WHO DISCONTINUED TREATMENT DUE TO IRAE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug aims to tame severe side effects, let cancer patients resume lifesaving treatment

Disease control Not yet recruiting

This study is testing a drug called Ivarmacitinib for people with advanced solid tumors who had to stop a promising type of cancer treatment (immunotherapy) because of severe side effects. The goal is to see if Ivarmacitinib can help control these side effects so that patients mi…

Matched conditions: PATIENTS WITH ADVANCED SOLID TUMORS WHO DISCONTINUED TREATMENT DUE TO IRAE

Phase: PHASE2 • Sponsor: Fujian Cancer Hospital • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

PATIENTS WITH ADVANCED SOLID TUMORS WHO DISCONTINUED TREATMENT DUE TO IRAE

Get alerted when new PATIENTS WITH ADVANCED SOLID TUMORS WHO DISCONTINUED TREATMENT DUE TO IRAE trials appear

New drug aims to tame severe side effects, let cancer patients resume lifesaving treatment